FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135519711> ?p ?o ?g. }

• W3135519711 endingPage "475" @default.
• W3135519711 startingPage "470" @default.
• W3135519711 abstract "Daratumumab is an anti-CD38 monoclonal antibody widely used for treating patients with newly diagnosed or relapsed/refractory multiple myeloma. The subcutaneous formulation of daratumumab was developed with the purpose of minimizing the treatment burden (to patients and health care system) associated with intravenous daratumumab. Given its recent approval, there is a knowledge gap regarding the best practices that should be instituted for safe administration of subcutaneous daratumumab.A retrospective chart review was performed from August 2020 until November 2020 to identify patients either switched to or treated upfront (daratumumab naive) with any subcutaneous daratumumab-based treatment regimen. All patients received appropriate premedications per institutional standards of care. The study end points were to report real-world data regarding administration-related reaction rates (at or following discharge from infusion center), as well as compare their incidence rates to those noted in the COLUMBA study (historical cohort).The study included 58 patients, of whom 38% (n = 22) were daratumumab naive. The majority (84%, n = 49) received subcutaneous daratumumab in combination with various antimyeloma regimens. There were no cases of administration-related reactions at infusion center or after discharge irrespective of previous exposure to intravenous daratumumab. None of the patients included herein required rescue home medications or visited the emergency department within 24 to 48 hours after subcutaneous daratumumab administration. These translated into a significant difference in incidence of administration-related reactions compared with historical cohort (0% vs. 13%, P = .003).Subcutaneous daratumumab was extremely well tolerated and could be safely administered without need for monitoring or rescue home medications." @default.
• W3135519711 created "2021-03-15" @default.
• W3135519711 creator A5006796378 @default.
• W3135519711 creator A5018575643 @default.
• W3135519711 creator A5037194248 @default.
• W3135519711 creator A5042487436 @default.
• W3135519711 creator A5044657129 @default.
• W3135519711 creator A5045179755 @default.
• W3135519711 creator A5051577163 @default.
• W3135519711 creator A5055912150 @default.
• W3135519711 creator A5066736084 @default.
• W3135519711 creator A5071438752 @default.
• W3135519711 creator A5075688184 @default.
• W3135519711 creator A5083639923 @default.
• W3135519711 date "2021-07-01" @default.
• W3135519711 modified "2023-10-17" @default.
• W3135519711 title "Transition from Intravenous to Subcutaneous Daratumumab Formulation in Clinical Practice" @default.
• W3135519711 cites W1902692042 @default.
• W3135519711 cites W2512106959 @default.
• W3135519711 cites W2528329272 @default.
• W3135519711 cites W2609872450 @default.
• W3135519711 cites W2611645469 @default.
• W3135519711 cites W2688500010 @default.
• W3135519711 cites W2772566228 @default.
• W3135519711 cites W2890161608 @default.
• W3135519711 cites W2936234467 @default.
• W3135519711 cites W2945434115 @default.
• W3135519711 cites W2947874495 @default.
• W3135519711 cites W2948728876 @default.
• W3135519711 cites W2996752315 @default.
• W3135519711 cites W3009982759 @default.
• W3135519711 cites W3012570191 @default.
• W3135519711 cites W3014227371 @default.
• W3135519711 cites W3046852274 @default.
• W3135519711 cites W3081620756 @default.
• W3135519711 cites W3105288820 @default.
• W3135519711 doi "https://doi.org/10.1016/j.clml.2021.02.014" @default.
• W3135519711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33785299" @default.
• W3135519711 hasPublicationYear "2021" @default.
• W3135519711 type Work @default.
• W3135519711 sameAs 3135519711 @default.
• W3135519711 citedByCount "10" @default.
• W3135519711 countsByYear W31355197112021 @default.
• W3135519711 countsByYear W31355197112022 @default.
• W3135519711 countsByYear W31355197112023 @default.
• W3135519711 crossrefType "journal-article" @default.
• W3135519711 hasAuthorship W3135519711A5006796378 @default.
• W3135519711 hasAuthorship W3135519711A5018575643 @default.
• W3135519711 hasAuthorship W3135519711A5037194248 @default.
• W3135519711 hasAuthorship W3135519711A5042487436 @default.
• W3135519711 hasAuthorship W3135519711A5044657129 @default.
• W3135519711 hasAuthorship W3135519711A5045179755 @default.
• W3135519711 hasAuthorship W3135519711A5051577163 @default.
• W3135519711 hasAuthorship W3135519711A5055912150 @default.
• W3135519711 hasAuthorship W3135519711A5066736084 @default.
• W3135519711 hasAuthorship W3135519711A5071438752 @default.
• W3135519711 hasAuthorship W3135519711A5075688184 @default.
• W3135519711 hasAuthorship W3135519711A5083639923 @default.
• W3135519711 hasConcept C120665830 @default.
• W3135519711 hasConcept C121332964 @default.
• W3135519711 hasConcept C126322002 @default.
• W3135519711 hasConcept C141071460 @default.
• W3135519711 hasConcept C159110408 @default.
• W3135519711 hasConcept C2776364478 @default.
• W3135519711 hasConcept C2776390293 @default.
• W3135519711 hasConcept C2777478702 @default.
• W3135519711 hasConcept C2780724011 @default.
• W3135519711 hasConcept C2781119759 @default.
• W3135519711 hasConcept C61511704 @default.
• W3135519711 hasConcept C71924100 @default.
• W3135519711 hasConcept C72563966 @default.
• W3135519711 hasConceptScore W3135519711C120665830 @default.
• W3135519711 hasConceptScore W3135519711C121332964 @default.
• W3135519711 hasConceptScore W3135519711C126322002 @default.
• W3135519711 hasConceptScore W3135519711C141071460 @default.
• W3135519711 hasConceptScore W3135519711C159110408 @default.
• W3135519711 hasConceptScore W3135519711C2776364478 @default.
• W3135519711 hasConceptScore W3135519711C2776390293 @default.
• W3135519711 hasConceptScore W3135519711C2777478702 @default.
• W3135519711 hasConceptScore W3135519711C2780724011 @default.
• W3135519711 hasConceptScore W3135519711C2781119759 @default.
• W3135519711 hasConceptScore W3135519711C61511704 @default.
• W3135519711 hasConceptScore W3135519711C71924100 @default.
• W3135519711 hasConceptScore W3135519711C72563966 @default.
• W3135519711 hasFunder F4320308295 @default.
• W3135519711 hasIssue "7" @default.
• W3135519711 hasLocation W31355197111 @default.
• W3135519711 hasLocation W31355197112 @default.
• W3135519711 hasOpenAccess W3135519711 @default.
• W3135519711 hasPrimaryLocation W31355197111 @default.
• W3135519711 hasRelatedWork W2002120878 @default.
• W3135519711 hasRelatedWork W2026095104 @default.
• W3135519711 hasRelatedWork W2047967234 @default.
• W3135519711 hasRelatedWork W2118496982 @default.
• W3135519711 hasRelatedWork W2435227317 @default.
• W3135519711 hasRelatedWork W2439875401 @default.
• W3135519711 hasRelatedWork W2979880696 @default.
• W3135519711 hasRelatedWork W2980093723 @default.

• next